Advertisement

Xenotransplantation of encapsulated porcine islets

  • Anthony M. Sun

Abstract

Interspecies tissue and organ transplants (xenografts) have been imagined but not attained for thousands of years. Type 1 diabetic individuals depended for survival on insulin of xenogeneic origin (pigs and cows) from Banting and Best’s first report in 1922 until the introduction of recombinant human insulin in the 1980s. A logical though until now impossible extension of the use of xenogeneic cell products is direct implantation of living xenogeneic cells. Researchers attempting this objective have had to deal with two key problems: (i) How many islets (or beta cells) are needed and where should they be implanted? (ii) What protective measures must be applied to protect islet viability? Sun, recounts his efforts to overcome both immunorejection and autoimmune rejection by immunoisolation of pancreatic islets. By first encasing rat islets in a semipermeable alginate-polysine-alginate microcapsule and then injecting encapsulated islets into induced diabetic mice, islet viability of 70–90% was attained for 3 months. Subsequently, a reproducible technique for porcine islet isolation was used to treat spontaneously diabetic cynomolgus monkeys with seven of nine monkeys rendered insulin independent for as long as 804 days. Sporadic successes using diverse techniques to implant islets in type 1 diabetic humans have been reported for two decades, each time engendering enthusiasm that a solution had been found. There is enough promise in the concept of microencapsulating xenogeneic islets to prompt an active clinical trial in China.

Keywords

Pancreatic Islet Diabetic Mouse Diffusion Chamber Insulin Independence Guluronic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Diabetes Control and Complicat ions Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulindependent diabete s mellitus. N Engl J Med 1993; 329: 977–986.CrossRefGoogle Scholar
  2. 2.
    Sollinger HW, Stratta RJ, D’Alessando AM, Kalayoglu M, Pirsch JD, Beizer FO. Experience with simultaneous pancreas-kidney transplantation. Ann Surg 1988; 208: 475–483.PubMedCrossRefGoogle Scholar
  3. 3.
    Faustman D, Hauptfeld V, Davie M, Lacy PE, Shreffler DC. Murine pancreatic beta cells express H2K and H2D but not Ia antigens. Exp Med 1980; 151: 1563–1568.CrossRefGoogle Scholar
  4. 4.
    Ricordi C, Kraus C, Lacy PE. Effect of low-temperature culture on the survival of intratesticular rat islet allografts. Transplantation 1988; 45: 465–468.Google Scholar
  5. 5.
    Woehrle M, Markmann JF, Silvers WK, Barker CF, Naji A. Transplantation of cultured pancreatic islets to BB rats. Surgery 1986; 100: 334–340.PubMedGoogle Scholar
  6. 6.
    Kenyon NS, Strasser S, Alejandro R. Ultraviolet light immunomodulation of canine islets for prolongation of allograft survival. Diabetes 1990; 39: 305–311.PubMedCrossRefGoogle Scholar
  7. 7.
    Cattral M, Wornock G, Evans M, Rajotte R. Transplantation of purified single-donor cryopreserved canine islet allografts with cyclosporine. Transplant Proc 1991; 23: 777–778.PubMedGoogle Scholar
  8. 8.
    Alejandro R, Latif Z, Noel J, Shienvold FL, Mintz DH. Effect of anti-la antibodies, culture and cyclosporin on prolongation of canine islet allograft survival. Diabetes 1987; 36: 269–273.PubMedCrossRefGoogle Scholar
  9. 9.
    Lim F, Sun AM. Microencapasulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908.PubMedCrossRefGoogle Scholar
  10. 10.
    Sun AM, O’Shea GM, Goosen MFA. Injectable, biocompatible islet microcapsules as a bioartificial pancreas. Prog Artif Organs 1983: 769.Google Scholar
  11. 11.
    Sun AM, O’Shea GM, Gharapetian H. Artificial cells containing islets as bioartificial pancreas. Prog Artif Organs 1986: 601.Google Scholar
  12. 12.
    O’Shea GM, Sun AM. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. J Am Diabetes Assoc 1986; 35: 943.Google Scholar
  13. 13.
    Hommel M, Sun AM. Droplet generation. Canadian Patent 458605.1984.Google Scholar
  14. 14.
    Weber C, Zabinski S, Koschitzky T et al. The role of CD+ helper T cells in the destruction of microencapsulated islet xenografts in NOD mice. Transplantation 1990; 49: 396–404.PubMedCrossRefGoogle Scholar
  15. 15.
    Ricker A, Stockberger S, Halban P. Hyperimmune response in microencapsulated xenogeneic tissue in non-obese mice. In: Javorski M (ed.), The Immunology of Diabetes Mellitus. Elsevier, Amsterdam; 1988: 93–200.Google Scholar
  16. 16.
    Cole DR, Waterfall X, Mclntyre X, Bayrd JD. Site modification of inflammatory response in alginate-polylysine-alginate microcapsules in BB/Edinburg rats. Diabetic Medicine 1991; 6(Suppl 1): A41.Google Scholar
  17. 17.
    Soon-Shiong P, Feldman E, Nelson R. Successful reversal of spontaneous diabetes in dogs by intraperitoneal transplants of microencapsulated islets. Transplantation 54: 769–774.Google Scholar
  18. 18.
    Clayton HA, London NJM, Collob PS, Bell PRF, James PEL. The effect of capsule composition on the biocompatibility of alginate-poly-L-lysine capsules. J Microcapsulation 1991; 8: 221–223.CrossRefGoogle Scholar
  19. 19.
    Zimmerman U, Klock GK, Federlin K, Hannig L, Kowalski M, Bretzel MRG, Horcher, Entemann H. Production of mitogen contamination free alginate with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 1992; 13: 269–274.CrossRefGoogle Scholar
  20. 20.
    Lanza RP, Sullivan SJ, Chick WL. Islet transplantation with immunoisolation. Diabetes 1992; 41: 1503–1510.PubMedCrossRefGoogle Scholar
  21. 21.
    Fan M, Lum Z, Fu X, Levesque L, Tai I, Sun A. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990; 39: 519.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Shea G, Sun A. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice. Diabetes 1986, 35: 943.PubMedCrossRefGoogle Scholar
  23. 23.
    Lum ZP, Krestow M, Isabella T, Vacek I, Sun A. Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. Transplantation 1992; 53: 1180.PubMedCrossRefGoogle Scholar
  24. 24.
    Lum Z, Tai I, Krestow M et al. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 1991; 40: 1511.PubMedCrossRefGoogle Scholar
  25. 25.
    Ricker A, Stockberger A. Hyperimmune response to microencapsulated xenogenic tissue (Abstract). Diabetes 1980; 35: 649.Google Scholar
  26. 26.
    Krestow M, Lum Z, Tai I et al. Xenotransplantation of microencapsulated fetal rat islets. Transplantation 1991; 51: 651.PubMedCrossRefGoogle Scholar
  27. 27.
    Sun Y, Ma X, Zhou D et al. Porcine pancreatic islets: isolation, microencapsulation and xenotransplantation. Artificial Organs 1993; 17: 727.PubMedCrossRefGoogle Scholar
  28. 28.
    Sun Y, Ma X, Zhou D, Vacek I Vacek I. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosup-pression. J Clin Invest 1996; 98: 1417.PubMedCrossRefGoogle Scholar
  29. 29.
    Ma X, Vacek I, Sun A. Generation of alginate-polylysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and and the reaction conditions. Biomater. Artif Cells Immobilization Biotechnol 1994; 22: 43.Google Scholar
  30. 30.
    Soon-Shiong P et al. Successful reversal of spontaneous diabetes in dogs by intraperitoneal transplants of microencapsulated islets. Transplantation 1992; 54: 769–774.PubMedCrossRefGoogle Scholar
  31. 31.
    Soon-Shiong P, Feldman E, Nelson R et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Nat Acad Sci USA 1993; 90: 5843–5847.PubMedCrossRefGoogle Scholar
  32. 32.
    Calafiore R. Transplantation of microencapsulated pancreatic islets for therapy of diabetes mellitus. ASAIO Transactions 1992; 38: 34.CrossRefGoogle Scholar
  33. 33.
    Soon-Shiong P et al. Insulin independence in a Type I diabetic patient after encapsulated islet transplantation. Lancet 1994; 343: 950.PubMedCrossRefGoogle Scholar
  34. 34.
    Clayton H, James R, London N. lslet microencapsulation: a review. Acta diabetologica 1993; 30: 181.PubMedCrossRefGoogle Scholar
  35. 35.
    Braun K, Besch W, Jahr H, Loth F, Dautzenberg H, Hahn H. The encapsulation of pancreatic islets: investigation of insulin secretion and content in vitro. Biomed Biochim Acta 1985; 44: 143.PubMedGoogle Scholar
  36. 36.
    Braun K, Besch W, Lucke S, Hahn H. The long term culture of encapsulated pancreatic islets. Exp Clin Endocrinol 1986; 87: 313.PubMedCrossRefGoogle Scholar
  37. 37.
    Braun K, Kauert C, Dunger A, Hahn H. Allogenic transplantation of microencapsulated islets. Transplant Proc 1987; 19: 931.PubMedGoogle Scholar
  38. 38.
    Gin H, Dupuy B, Baquey A, Ducassou D. Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks of implantation in the rat: influence of the complement. J Microencapsulation 1990; 7: 341.PubMedCrossRefGoogle Scholar
  39. 39.
    Sefton M, Broughton R, Sugamori M, Mallabone C. Hydrophilic polyacrylates for the microencapsulation of fibroblasts or pancreatic islets. J Controlled Release 1987; 6: 177.CrossRefGoogle Scholar
  40. 40.
    Sugamori M, Sefton M. Microencapsulation of pancreatic islets in a water insoluble polyacrylate. Trans Am Soc Artif Intern Organs 1989; 35: 791.Google Scholar
  41. 41.
    Tatarkiewicz K. New membrane for cell encapsulation. Artif Organs 1988; 12: 446.PubMedCrossRefGoogle Scholar
  42. 42.
    Iwata H, Amemiya H, Matsuda T et al. In vitro and in vivo evaluation of microencapsulated islets as hybrid artificial pancreas. Jpn J Artif Organs 1986; 15: 1493.Google Scholar
  43. 43.
    Iwata H, Matsuda T, Amememiya H et al. Microencapsulation of islets and its application to xenograft as a bioartificial pancreas. Artif Organs 1987; 11, 315.Google Scholar
  44. 44.
    Iwata H, Amemyia H, Matsuda H et al. The molecular weighfraction of semipermeable membrane for encapsulation of a hybrid artificial pancreas: the essential component of the permeable membrane at molecular weight ranges fo maintaining the function of the pancreatic islets of Lagerhans. Jpn J Artif Organs 1988; 17: 208.Google Scholar
  45. 45.
    Iwata H, Amemyia H, Matsuda T, Takano H, Hayashi R, Akutsu T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormon secretion in culture and xenotransplantation. Diabetes 1989, 38(Suppl 1): 224.PubMedGoogle Scholar
  46. 46.
    Lanza R, Kuhtreiber W, Ecker D, Staruk J, Chick W. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995; 59: 1377.PubMedCrossRefGoogle Scholar
  47. 47.
    Lanza, Ecker D, Kuhtreiber, Staruk J, Marsh J, Chick W. A simple method for transplanting discordant islets into rats using alginate gel spheres. Transplantation 1995; 59: 1485.PubMedCrossRefGoogle Scholar
  48. 48.
    Wang T, Lacik I, Brissova M. An encapsulation system for immunoisolation of pancreatic islets. Nature Biotechnology 1997; 15: 358.PubMedCrossRefGoogle Scholar
  49. 49.
    Jindal R, Gray D. Preservation and storage of pancreatic islets. Transplantation 1994; 57: 317.PubMedCrossRefGoogle Scholar
  50. 50.
    Rajotte R. Cryopreservation of pancreatic islets. Transplant Proc 1994; 26: 395.PubMedGoogle Scholar
  51. 51.
    Rich S, Swift S, Thirdborough S, James R, Bell P, London N. Islet cryopreservation: a detailed study of total functional losses. Transplant Proc 1994; 26: 823.PubMedGoogle Scholar
  52. 52.
    Inaba K, Zhou D, Yang B et al. Normalization of diabetes by xenotransplantation of cryopreserved microencapsulated pancreatic islets. Transplantation 1996; 61:175.PubMedCrossRefGoogle Scholar
  53. 53.
    Marchetti P, Scharp D, Pfiffner K, Swanson C, Finke E, Olack B, Gerasimidieou A, McLear M, Lacy P. Cryogenic storage of isolated, purified porcine pancreatic islets. Transplantation 1994; 57: 340.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Anthony M. Sun

There are no affiliations available

Personalised recommendations